First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search for therapies for psychiatric disorders
2021/41/B/NZ7/04275
Keywords
Descriptors
- NZ7_014: Farmacja, farmakoterapia, farmakologia
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Jagielloński, Collegium Medicum
Voivodeship: małopolskie
Principal investigator (from the host institution)
prof. Marcin Roman Kołaczkowski
Number of co-investigators in the project: 17
Call
OPUS 21 – announced on 2021-03-15
- Amount awarded
- 2 991 854 PLN
- Project start date
- 2022-02-07
- Project end date
- 2027-02-06
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.